BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
BIO KEY INTERNATIONAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.27−0.36 (-13.69%)
Close on Oct 19, 2026
- Market cap
- $2.35M
- P/E (TTM)
- –
- Dividend yield
- –
Bio Key International statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Prepackaged Software companies for comparison
Valuation
| Measure | Bio Key International | Industry median |
|---|---|---|
| Market Cap | $3.26M | $288.35M |
| Enterprise Value | $1.88M | $295.96M |
| PS Ratio | 0.49 | 2.36 |
| PB Ratio | 0.75 | 2.67 |
| P/TBV Ratio | 0.90 | 4.90 |
Enterprise value
| Measure | Bio Key International | Industry median |
|---|---|---|
| EV / Sales | 0.28 | 2.14 |
Income (trailing twelve months)
| Measure | Bio Key International | Industry median |
|---|---|---|
| Revenue | $6.70M | $285.88M |
| Gross Profit | $5.45M | $158.88M |
| Operating Income | -$5.79M | -$627.44K |
| Pretax Income | -$6.02M | -$295.11K |
| Net Income | -$6.04M | -$298.85K |
| EBITDA | -$5.79M | -$186.20K |
| EPS (Diluted) | -$6.82 | $0.00 |
Margins
| Measure | Bio Key International | Industry median |
|---|---|---|
| Gross Margin | 81.3% | 55.8% |
| Operating Margin | -86.4% | -1.97% |
| Pretax Margin | -89.9% | -0.50% |
| Profit Margin | -90.1% | -1.84% |
| EBITDA Margin | -86.4% | 0.49% |
| FCF Margin | -62.1% | 10.0% |
Returns
| Measure | Bio Key International | Industry median |
|---|---|---|
| Return on Equity (ROE) | -107.9% | 1.05% |
| Return on Assets (ROA) | -67.1% | -3.10% |
| Return on Invested Capital (ROIC) | -121.5% | -0.51% |
| Return on Capital Employed (ROCE) | -129.5% | -0.46% |
Growth
| Measure | Bio Key International | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -3.07% | 9.79% |
| Revenue Growth (3Y CAGR) | -5.43% | 7.56% |
| Revenue Growth (5Y CAGR) | 15.9% | 12.3% |
Balance sheet
| Measure | Bio Key International | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.38M | $43.10M |
| Net Cash (Debt) | $1.38M | $1.87M |
| Net Cash Per Share | $0.96 | $0.14 |
| Equity (Book Value) | $4.33M | $52.02M |
| Book Value Per Share | $3.02 | $1.91 |
| Tangible Book Value | $3.62M | $3.03M |
| Working Capital | $793.45K | $14.05M |
Financial position
| Measure | Bio Key International | Industry median |
|---|---|---|
| Current Ratio | 1.26 | 1.39 |
| Quick Ratio | 1.03 | 0.93 |
| Interest Coverage | -108.41 | -0.66 |
Cash flow (trailing twelve months)
| Measure | Bio Key International | Industry median |
|---|---|---|
| Operating Cash Flow | -$4.16M | $8.52M |
| Capital Expenditures | -$5.96K | -$5.59M |
| Free Cash Flow | -$4.16M | $47.39M |
| FCF Per Share | -$2.90 | $0.69 |
Efficiency
| Measure | Bio Key International | Industry median |
|---|---|---|
| Asset Turnover | 0.74 | 0.63 |
| Inventory Turnover | 3.61 | 14.46 |
| Revenue Per Employee | $159.50K | $393.50K |
| Profits Per Employee | -$143.71K | -$4.74K |
| Employee Count | 42 | 530 |
Dividends and yields
| Measure | Bio Key International | Industry median |
|---|---|---|
| Earnings Yield | -185.1% | -0.95% |
| FCF Yield | -127.7% | 4.01% |
Shares
| Measure | Bio Key International | Industry median |
|---|---|---|
| Shares Outstanding | 1,436,340 | 59,289,300 |
| Shares Change (YoY) | 136.8% | 2.27% |
| Shares Change (QoQ) | 0.18% | 0.06% |
| Float | 239,418 | 52,876,900 |
| Shares Held by Insiders | 83.3% | 13.2% |
| Shares Held by Institutions | 0.00% | 66.9% |
Taxes
| Measure | Bio Key International | Industry median |
|---|---|---|
| Income Tax | $16.50K | $1.64M |
Scores
| Measure | Bio Key International | Industry median |
|---|---|---|
| Altman Z-Score | -26.59 | 1.50 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -3.18 | -2.81 |
Calculated by StockData from Bio Key International's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.